← Back to all trials
Enrolling By Invitation
NCT05598775
Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Phase 2b Study
Conditions: Ischemic Stroke
Sex: All
Ages: 35 Years – 75 Years
Enrollment: 9
Sponsor: ReNeuron Limited
Location: United States
Summary
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival
Eligibility Criteria
Inclusion Criteria:Subjects who have received CTX0E03 DP as part of the active arm in the PISCES III study Have provided appropriate written informed consentExclusion Criteria:None
Source: ClinicalTrials.gov (NCT05598775). StuddyBuddy aggregates publicly available trial information.
